KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Operating Expenses: 2009-2024

Historic Operating Expenses for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Dec 2024 value amounting to $11.3 billion.

  • Vertex Pharmaceuticals' Operating Expenses rose 14.17% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 billion, marking a year-over-year decrease of 29.06%. This contributed to the annual value of $11.3 billion for FY2024, which is 86.39% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Operating Expenses stood at $11.3 billion for FY2024, which was up 86.39% from $6.0 billion recorded in FY2023.
  • Vertex Pharmaceuticals' Operating Expenses' 5-year high stood at $11.3 billion during FY2024, with a 5-year trough of $3.3 billion in FY2020.
  • Over the past 3 years, Vertex Pharmaceuticals' median Operating Expenses value was $6.0 billion (recorded in 2023), while the average stood at $7.3 billion.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Operating Expenses decreased by 3.53% in 2022 and then spiked by 86.39% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' Operating Expenses (Yearly) stood at $3.3 billion in 2020, then skyrocketed by 43.08% to $4.8 billion in 2021, then declined by 3.53% to $4.6 billion in 2022, then surged by 30.58% to $6.0 billion in 2023, then skyrocketed by 86.39% to $11.3 billion in 2024.